Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy D Bohart

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 24, 2025
A review of sunscreen in the prevention of skin cancerJohn P Micha, Randy D Bohart, Bram H Goldstein
Expert Review of Anticancer Therapy|June 17, 2026
The potential impact of glucagon-like peptide 1 receptor agonists for the treatment of endometrial carcinomaJohn P Micha, Randy D Bohart, Bram H Goldstein
Archives of Gynecology and Obstetrics|April 6, 2023
Reply to the letter to the editor: a response to Tran and EgilmanJohn P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
Journal of Menopausal Medicine|September 7, 2022
Hormone Therapy and Risk of Breast Cancer: Where Are We Now?John P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
Expert Review of Anticancer Therapy|November 5, 2024
Statin use and ovarian cancer outcomesJohn P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
Journal of Gynecologic Oncology|December 12, 2022
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinomaJohn P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
The Journal of Obstetrics and Gynaecology Research|February 1, 2023
Prolonged endocrine therapy in the management of hormone receptor-positive early-stage breast cancer: What is the appropriate duration?John P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
Anticancer Research|June 27, 2025
Immunotherapy and Chemotherapy for Advanced or Recurrent Endometrial CarcinomaJohn P Micha, Randy D Bohart, Joshua P Gorman, et al.
Journal of Robotic Surgery|February 17, 2024
Current analysis of the survival implications for minimally invasive surgery in the treatment of early-stage cervix cancerJohn P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
Cancer Investigation|July 5, 2024
Does Aspirin Use Reduce the Risk for Ovarian Cancer?John P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 24, 2025
A review of sunscreen in the prevention of skin cancerJohn P Micha, Randy D Bohart, Bram H Goldstein
Expert Review of Anticancer Therapy|June 17, 2026
The potential impact of glucagon-like peptide 1 receptor agonists for the treatment of endometrial carcinomaJohn P Micha, Randy D Bohart, Bram H Goldstein
Archives of Gynecology and Obstetrics|April 6, 2023
Reply to the letter to the editor: a response to Tran and EgilmanJohn P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
Journal of Menopausal Medicine|September 7, 2022
Hormone Therapy and Risk of Breast Cancer: Where Are We Now?John P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
Expert Review of Anticancer Therapy|November 5, 2024
Statin use and ovarian cancer outcomesJohn P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
Journal of Gynecologic Oncology|December 12, 2022
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinomaJohn P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
The Journal of Obstetrics and Gynaecology Research|February 1, 2023
Prolonged endocrine therapy in the management of hormone receptor-positive early-stage breast cancer: What is the appropriate duration?John P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
Anticancer Research|June 27, 2025
Immunotherapy and Chemotherapy for Advanced or Recurrent Endometrial CarcinomaJohn P Micha, Randy D Bohart, Joshua P Gorman, et al.
Journal of Robotic Surgery|February 17, 2024
Current analysis of the survival implications for minimally invasive surgery in the treatment of early-stage cervix cancerJohn P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
Cancer Investigation|July 5, 2024
Does Aspirin Use Reduce the Risk for Ovarian Cancer?John P Micha, Mark A Rettenmaier, Randy D Bohart, et al.
Pageof 2